Next Article in Journal
Chemical Characterization of Flowers and Leaf Extracts Obtained from Turnera subulata and Their Immunomodulatory Effect on LPS-Activated RAW 264.7 Macrophages
Next Article in Special Issue
Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
Previous Article in Journal
Stealth Liposomes (PEGylated) Containing an Anticancer Drug Camptothecin: In Vitro Characterization and In Vivo Pharmacokinetic and Tissue Distribution Study
Previous Article in Special Issue
Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 3
10.3390/molecules27031089
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex

by
Eman M. Fathalla
1,
Mezna Saleh Altowyan
2,
Jörg H. Albering
3,
Assem Barakat
4,
Morsy A. M. Abu-Youssef
1,*,
Saied M. Soliman
1,* and
Ahmed M. A. Badr
1
1
Department of Chemistry, Faculty of Science, Alexandria University, P.O. Box 426, Ibrahimia, Alexandria 21321, Egypt
2
Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia
3
Graz University of Technology, Mandellstr. 11/III, A-8010 Graz, Austria
4
Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Molecules 2022, 27(3), 1089; https://doi.org/10.3390/molecules27031089
Submission received: 10 January 2022 / Revised: 1 February 2022 / Accepted: 4 February 2022 / Published: 6 February 2022
(This article belongs to the Special Issue Synthesis of Organic Ligands and Their Metal Complexes in Medicinal Chemistry)
Browse Figures
Versions Notes

Abstract

:
The reaction of 4-hydroxyquinazoline (4HQZ) with aqueous solution of nitric acid afforded the corresponding quinazolinone-nitrate (4HQZN) complex in very good yield. The crystal structure of 4HQZN was determined and its structural and supramolecular structural aspects were analyzed. 4HQZN crystallized in the space group P21/c and monoclinic crystal system with one [4HQZ-H]+[NO3]− formula and Z = 4. Its supramolecular structure could be described as a 2D infinite layers in which the 4HQZN molecules are connected via N-H…O and C-H…O hydrogen bridges. Using DFT calculations, the relative stability of five suggested isomers of 4HQZN were predicted. It was found that the medium effects have strong impact not only on the isomers’ stability but also on the structure of the 4HQZN. It was found that the structure of 4HQZN in DMSO and methanol matched well with the reported X-ray structure which shed the light on the importance of the intermolecular interactions on the isomers’ stability. The structure of 4HQZN could be described as a proton transfer complex in which the nitrate anion acting as an e-donor whiles the protonated 4HQZ is an e-acceptor. In contrast, the structure of the isolated 4HQZN in gas phase and in cyclohexane could be described as a 4HQZ…HNO3 hydrogen bonded complex. Biological screening of the antioxidant, anticancer and antimicrobial activities of 4HQZ and 4HQZN was presented and compared. It was found that, 4HQZN has higher antioxidant activity (IC50 = 36.59 ± 1.23 µg/mL) than 4HQZ. Both of 4HQZ and 4HQZN showed cell growth inhibition against breast (MCF-7) and lung (A-549) carcinoma cell lines with different extents. The 4HQZ has better activity with IC50 of 178.08 ± 6.24 µg/mL and 119.84 ± 4.98 µg/mL, respectively. The corresponding values for 4HQZN are 249.87 ± 9.71 µg/mL and 237.02 ± 8.64 µg/mL, respectively. Also, the antibacterial and antifungal activities of 4HQZN are higher than 4HQZ against all studied microbes. The most promising result is for 4HQZN against A. fumigatus (MIC = 312.5 μg/mL).

1. Introduction

In organic chemistry, 5- or 6-membered rings containing oxygen, nitrogen, or sulphur atom are the most abundant natural heterocycles [1,2]. Quinazoline (1,3-diazanaphthalene) is a nitrogen-containing fused heterocycle [3,4] consisting of two fused 6-membered simple aromatic rings: a benzene and a pyrimidine [5,6]. Quinazolines have a broad range of pharmacological applications, in addition to their low toxicity profiles [3]. Quinazoline frameworks have great pharmacological activities as antioxidant [7,8,9], antidiabetic [10,11,12], antibacterial [13,14,15], antiviral [16,17,18], antimicrobial [19,20,21], anticancer [22,23], antihistaminic [24,25,26], antidiuretic [27,28], antitubercular [29,30,31], and anti-inflammatory [32,33,34] agents. Quinazolinones are a type of quinazoline derivative that are biologically active in the same way as quinazoline [35]. There are various medications that include quinazoline and quinazolinone rings, such as raltitrexed, a quinazolinone-based medicine, which is used to treat large intestine cancer, whereas methaqualone is a sedative drug, albaconazole is an antifungal drug and proquazone is a non-steroidal anti-inflammatory drug (Figure 1) [36,37,38,39].
There has been a lot of effort in investigating the tautomerism of heterocyclic systems during the past two decades in order to figure out how tautomerism affects molecules chemically and biologically. Understanding the varied features of tautomers would require a careful investigation of the structure and changes in both geometrical and energetic variables produced via the transfer of hydrogen atoms. From the standpoint of structural chemistry, understanding the comparative stabilities of the tautomers or isomers of heterocycles, and even the transformation between different isomeric forms, is a critical [40]. Environmental factors such as solvent polarity are extremely important in heterocyclic tautomeric equilibria [41,42,43,44,45,46,47,48]. In this regard, 4-hydroxyquinazoline (4-HQZ) could exist as the four possible isomers as shown in Figure 2. In 2011 Polat et al. [49], reported the properties of structure and energy of the different isomers of 4-HQZ. They reported that the most stable form is tautomer A in both the gaseous and aqueous phases based on DFT calculations, and the sequence of tautomer stability in the gas phase is A > B > C > D.
Given the relevance of the quinazoline derivatives, we report here the synthesis of the nitrate salt of 4HQZ (4HQZN). The structure of the 4HQZN was characterized using elemental analysis and FTIR spectroscopy as well as single crystal X-ray diffraction. Its supramolecular structure aspects were analyzed using Hirshfeld calculations. Also, a detailed examination for the stability of all potential isomers of 4HQZN (Figure 3) in various media such as methanol, DMSO and cyclohexane was performed using DFT quantum chemical simulations. Finally, we examined the antioxidant, anticancer and antimicrobial activities of 4HQZN compared to the free 4HQZ.

2. Results and Discussion

2.1. Synthesis and Chracterizations

The compound 4HQZN was synthesized using the direct reaction between 4HQZ and nitric acid. The structure of 4HQZN was identified using elemental analysis, FTIR and single crystal X-ray diffraction. Similar to the free 4HQZ, the corresponding salt 4HQZN could exist in the five isomeric forms shown in Figure 3. X-ray structure analysis revealed with no doubt the presence of the 4HQZN in the form E1 in the solid crystalline form. In this regard, comparative studies for the stability of the different isomeric forms of 4HQZN in gas phase and in solution were elucidated using DFT calculations. In addition, the supramolecular structural details of 4HQZN were also investigated based on Hirshfeld calculations. Its bioactivity as antioxidant, anticancer and antimicrobial agent were determined and compared with the free 4HQZ.

2.2. Structure Description

The compound 4HQZN crystallizes in the space group P21/c with one formula unit of the salt [4HQZ-H]+[NO3]− per asymmetric unit. The elementary cell contains a total of Z = 4 formula units (Table S1; Supplementary Materials). The interatomic distances and bond angles—except those involving hydrogen atoms can be taken from Table 1. Figure 4 shows one cation and one anion of the structure of 4HQZN.
The carbon atoms of the benzene ring (C3C4C5C6C7C8) show the interatomic distances expected for a delocalized π-electron system in the range from 1.3838(14) Å (C7-C8) to 1.4004(13) Å (C3-C8). The bond angles in this ring system also deviate only slightly from the ideal value of 120° (C6-C5-C4: 118.65(9)° and C5-C4-C3: 121.30(9)°). The bond distance between C2 and C3 of 1.4652(13) Å shows by its value between those for a typical single and a double bond that the carbonyl group is also involved in the π-electron system of the benzene ring. The bond length of C2-O4: 1.2141(12) Å found for the carbonyl group is within the normal range. All 11 atoms of the two ring systems of the cation deviate very little from planarity. The largest deviation occurs with the atom N2, which lies 0.039 Å below the averaged ring plane. The carbonyl oxygen, on the other hand, shows a deviation of 0.032 Å in the opposite direction. The plane of the amide group thus deviates by about 1.9° from the averaged ring plane of the entire cation.
The electron density map of the structure clearly shows that both nitrogen atoms are protonated. For the structure refinement, their B parameters were fixed to 1.5 times the values for respective nitrogen atoms, and the position was refined using the DFIX command in SHELX. Both N-H bond lengths are in the expected range: N2-H2 0.914(14) Å and N3-H3 0.875(15) Å. What has already been said about the organic cation in general also applies to the nitrate anion: no significant deviations occur with respect to the bond lengths and bond angles. All values can be taken from Table 1 and are within the normal range. Furthermore, there are no unusual deviations of the vibrational ellipsoids from the ideal spherical shape, neither for the organic cation nor for the nitrate anion.
The packing scheme of 4HQZN has a distinct layered structure. This can be seen particularly well in Figure 5B and Figure 6. Four layers of almost co-planar organic cations and nitrate ions cross the elementary cell parallel to the crystallographic b-axis. A closer look reveals that the molecular planes of anions and cations are not completely co-planar, but adopt an angle of 6.2° with respect to each other. This leads to a very weak corrugation of the layers.
Figure 7 shows the 2-dimensional infinite layers of alternately arranged anions and cations, which are linked by numerous hydrogen bonds. The layers defined by the approximately co-planar organic cations and the nitrate anions have two slightly different mean distances to each other of 2.768 Å and 2.878 Å, as shown in Figure 6. This is probably due to the fact that the ionic interactions between the layers are slightly different. These interactions are much stronger than the few π-π contacts of the organic molecules, and thus the ionic interactions dominate the formation of the comparatively short layer distances (for pure π-π stacking, distances in the range of about 3.2–3.4 Å would be common).
The 2-dimensional infinite layers in the structure of quinazolinone nitrate are composed of approximately co-planar aligned organic cations and nitrate anions in 1-dimensional infinite “bands”, approximately 11 Å wide, which are themselves infinitely linked in the second dimension via further weak hydrogen bonds through the carbonyl oxygen atoms O4 and the hydrogen H8 bound to C8 in the C6 ring system. Within the broad “bands”, nitrate ions arranged in a zig-zag pattern form the inner part, i.e., to a certain extent the analog of a backbone of a coordination polymer. Each nitrate ion is linked via its oxygen atoms twice (O2 and O3) or three times (O1) to protons of three neighboring organic cations via hydrogen bonds. The strongest interactions are N2-H2…O3 and N3-H3…O2 with donor-acceptor distances of 2.7943(11) Å and 2.7790(11) Å, respectively. Other hydrogen bonds with significantly longer contact distances are found for C1-H1…O3 (3.0961(12) Å), C1-H1…O1 (2.9920(13) Å), C5-H5…O1 (3.1953(13) Å), and for N2-H2…O1 (2.9950(12) Å). The linkage of the “bands” occurs through C8-H8…O4 interactions and relatively weak O…H contacts (2.50 Å). In spite of these subtle distinctions, one can rightly consider the layers as two-dimensional infinite.

2.3. Hirshfeld Analysis

The stability of the studied crystal is greatly determined by the intermolecular interactions occurring in it, most of these interactions could be quantitatively analyzed using Hirshfeld calculations. In the crystal structure of 4HQZN, there are four nitrate anions surrounding the protonated 4HQZ. To shed more insights on the intermolecular interactions in the crystal structure of 4HQZN, we performed the Hirshfeld analysis for the five fragments. The resulting Hirshfeld surfaces are presented in Figure 8.
Analysis of the fingerprint plots of these fragments indicated with no doubt that the four nitrate anion fragments have exactly the same pattern of intermolecular contacts as well as the same contributions for each contact. Hence, the contribution of these intermolecular contacts in only one fragment is presented in Figure 9. The most dominant contacts are the O…H interactions which contributed by 79.6% from the whole area of the fingerprint of the nitrate anion fragment (F2). In the dnorm map of the nitrate anion, there are a number of red spots corresponding to the O…H hydrogen bonds with the protonated 4HQZ cationic part (F1) where the O3…H2 (1.787 Å) is the shortest. In addition, there is another red spot related to the short C4…N1 (3.134 Å) contact (Figure 10). The latter contributed by only 2.1% from the whole fingerprint area.
The dnorm and fingerprint of the most important intermolecular contacts in the protonated 4HQZ fragment (F1) are summarized in Figure 11. It is clear that the O…H (38.9%), H…H (19.6%), C…H (18.8%) and C…O (11.5%) contacts represent the greatest contribution to the overall molecular packing interactions especially O…H hydrogen bonds. In addition to the short O3…H2 and C4…N1 interactions, the C…C (0.6%) and C…O contacts contribute significantly to the stability of the crystalline structure and appear in the dnorm map as red spots which indicate intermolecular interactions between atoms have shorter distances than sums of their vdW radii, while the white or blue areas refer to the less important interactions.
The significantly short O…H, C…O, C…N and C…C distances are collected in Table 3. In addition, the presence of short C2…C2 interaction between two staked aromatic ring system is indicative for little π-π stacking interactions due to the misfit of the two stacked ring from one another. Hence, the shape index map showed the characteristic red/blue triangles for π-π stacking interactions (Figure 11).

2.4. DFT Studies

2.4.1. Energetics and Stability

The studied compound 4HQZN could exist in the five possible isomers shown in Figure 3. Based on the energies and thermodynamic parameters presented in Table 4, their relative stability was predicted (Table 4). It was found that the isomer E4 has the lowest energy compared to the other isomers in the gas phase. Hence, E4 is the most stable one in that phase. The isomer E1 has higher energy than E4 by 9.607 kcal·mol−1 and is considered the second most stable form. Also, E4 is more stable than E1 by 6.534 kcal·mol−1 in a nonpolar solvent (cyclohexane). Hence, the most stable isomer in these cases is not the same as the one observed i X-ray single crystal structure. The higher stability of E4 compared to E1 could be attributed to the presence of two intramolecular hydrogen bonding interactions in the former while the latter is stabilized by only one intramolecular hydrogen bond (Figure 12). In accord with these results, the thermodynamic parameters indicated that isomer E4 is thermodynamically the most stable one in gas phase and in the nonpolar solvent cyclohexane (Table 4). In these medium, the order of the isomers’ stability is E4 ˃ E1 ˃ E2 ˃ E3 ˃ E5.
In contrast, the most stable isomer in methanol and DMSO as examples for polar protic and aprotic solvents, respectively, is E1 while the second most stable isomer is E4. The latter is energetically higher by 2.748 and 3.034 kcal·mol−1 than the former in methanol and DMSO, respectively. Interestingly, this observation agrees very well with the X-ray structure of 4HQZN. The question is why the situation is reversed in polar solvents? It is clear that the presence of intermolecular interactions with polar solvent molecules such as DMSO or methanol stabilized the E1 isomer in solution. Similarly, the intermolecular interactions occurred among the molecular units of 4HQZN molecules in the crystalline solid state structure have the upper hand on the existence of the 4HQZN in the form E1. As a result, the most stable isomer in polar solvents was found to be E1 which has similar situation to that in the solid state. In contrast, the intermolecular interactions in gas phase or in nonpolar solvent (cyclohexane) are neglected or almost weak, respectively. Hence, the intramolecular interactions are the dominant. As a result, the most stable isomer in these cases is E4 due to the presence of two intramolecular hydrogen bonding interactions instead of one in E1 (Table 5). These results shed the light on the importance of intra and inter-molecular interactions on the isomer’ stability.
It is obvious that the structure of 4HQZN in gas phase and cyclohexane comprised of a 4HQZ molecule hydrogen bonded with the HNO3 without a significant proton transfer where the O-H…N hydrogen bond distances in these cases are 1.640 and 1.563 Å, respectively. Hence, the structure of 4HQZN could be simply described as 4HQZ…HNO3 hydrogen bonded complex. In contrast, there is a significant proton transfer in the case of polar solvents such as DMSO and methanol where the 4HQZ seems to be protonated and the N-H…O hydrogen bond distances are 1.664 and 1.661 Å, respectively. In these cases, the structure is better to be described as a proton transfer complex of [4HQZ-H]+[NO3]−.

2.4.2. Optimized Geometry

The optimized bond distances and angles of the 4HQZN (isomer E1) in different solvents compared to the experimental X-ray structure results are listed in Table S2 (Supplementary Materials). There is no doubt about the better agreement between the calculated geometric parameters in DMSO and methanol with the X-ray crystal structure than those obtained from the optimized geometry in gas phase or in cyclohexane. It is clear that, the labile proton H3 is bonded with the more electronegative oxygen atom O2 of nitrate ion in both gas phase and in cyclohexane where the electrostatic interactions are predominant in these cases (Figure 12). The O2-H3 bond distances are predicted to be 1.033 and 1.055 Å in gas phase and cyclohexane, respectively. In contrast, in case of solutions of polar solvents like methanol and DMSO this proton (H3) appears to behave differently where these solvents effectively solvate the O-atoms of the NO3− ion leading to a proton transfer to the nitrogen atom of the 4HQZ moiety as indicated from the short N3-H3 bond which agreed with the X-ray structure. The calculated N-H distances are 1.059 and 1.058 Å in methanol and DMSO, respectively.

2.4.3. Frontier Molecular Orbitals (FMOs) and Reactivity Descriptors

The HOMO and LUMO levels are important for understanding the intramolecular charge transfer [50,51]. Their energies are given in Table 6. It is clear that, the HOMO level is destabilized while LUMO level is stabilized in presence of polar solvents compared to that in the gas phase or in cyclohexane. As a consequence of the smaller decrease in the ELUMO compared to the increase in the EHOMO, the values of the HOMO-LUMO energy gap are less in polar solvents compared to those in the gas phase or in cyclohexane.
Presentation of the HOMO and LUMO levels of 4HQZN in different solvents is shown in Figure 13. In case of the hydrogen bonded system HNO3…4HQZ, the optimized structure of 4HQZN in gas phase and in cyclohexane, both HOMO and LUMO levels are delocalized over the 4HQZ π-system. Hence, the HOMO → LUMO excitation could be considered as intramolecular excitation within the 4HQZ moiety. In contrast, the HOMO level of the proton transfer complex 4HQZN at the optimized structure in DMSO and methanol is found located over the NO3− moiety while the LUMO level is delocalized over the protonated quinazoline ring π-system indicating an intermolecular HOMO → LUMO excitation. These differences could be main reasons for the variations in the HOMO-LUMO energy gap with the nature of solvent.

2.4.4. Natural Charge Population

Natural atomic charges were calculated in order to predict the extent of the charge transfer within the different structures of the isomer E1 depending on the nature of solvent. The results of the natural charges are listed in Table S3 (Supplementary Materials). In case of the 4HQZ…HNO3 hydrogen bonded system, the net charges at the 4HQZ moiety are predicted to be 0.093 e and 0.121 e in gas phase and cyclohexane, respectively. In contrast, the net charges at the HNO3 fragment are −0.093 e and −0.121 e, respectively. The corresponding value in the isolated fragments is zero. Hence, the 4HQZ acting as an electron donor whiles the HNO3 fragment is an electron acceptor. For the proton transfer complex 4HQZN, the net charges at the protonated 4HQZ are 0.898 and 0.897 e, in DMSO and methanol, respectively instead of +1 e. On the other hand, the net charges at the nitrate ion are −0.898 and −0.897 e, respectively, instead of −1 e. Hence, the latter acting as an electron donor whiles the former is the electron acceptor. The amounts of electrons transferred in these cases are 0.101 and 0.103 e, respectively. At the X-ray geometry, the corresponding value is 0.063 e.

2.5. Biological Studies

2.5.1. Antioxidant Activity

The DPPH [52,53] free radical scavenging assay enabled us to determine the antioxidant activity of 4HQZ and its nitrate salt 4HQZN (Tables S4 and S5; Supplementary Materials). For better clarity, the results are summarized graphically in Figure 14. It is clear that the antioxidant activity of 4HQZ is weak. The DPPH scavenging is only 23.76% at 1280 µg/mL compared to 91.89% for 4HQZN at the same concentration. Hence, the 4HQZN has higher antioxidant activity than 4HQZ and the former has IC50 value of 36.59 ± 1.23 µg/mL. In this regard, the 4HQZ has moderate antioxidant activity in comparison with ascorbic acid as reference standard (IC50 = 10.62 ± 0.78 µg/mL). It is clear that the presence of the nitrate ion could have a direct impact on the enhancement of the antioxidant activity of 4HQZN. In agreement with literature, the nitrate supplementation has the ability to operate as an antioxidant, inhibiting the generation of free radicals [54] which is found consistent with the higher antioxidant activity of 4HQZN than 4HQZ.

2.5.2. Cytotoxicity against Breast and Lung Carcinoma

The anticancer activities of the 4HQZ and 4HQZN against breast (MCF-7) and lung (A-549) carcinoma cell lines were examined. The cell viability values are listed in Tables S6–S9 (Supplementary Materials), respectively, and presented graphically in Figure 15 (upper part). Both of 4HQZ and 4HQZN showed cell growth inhibition against breast carcinoma MCF-7 cell line to different extents. Generally the results indicated that 4HQZ has better activity against breast carcinoma MCF-7 cell line with IC50 of 178.08 ± 6.24 µg/mL than 4HQZN. The IC50 of the latter is higher (249.87 ± 9.71 µg/mL) indicating lower activity against breast carcinoma. In addition, the anticancer activity of the 4HQZ and 4HQZN against lung carcinoma A-549 cell line were also evaluated (Figure 15, lower part). Also, both compounds showed weak to moderate anticancer activity with IC50 values of 119.84 ± 4.98 and 237.02 ± 8.64 µg/mL. The lower IC50 values of the former compared to the latter indicated the better anticancer activity of 4HQZ than 4HQZN against this cell line.

2.5.3. Antimicrobial Activity

Different categories of microbes were used to examine the antimicrobial activity of 4HQZ and 4HQZN by determining the minimum inhibition zone diameters against these microbes at 10 mg/mL (Table 7).
The results shown in Table 7 leave no doubt about the antibacterial and antifungal activities of both compounds against the studied microbes. The only exception is 4HQZ which is found inactive against A. fumigatus at the applicable concentration while the inhibition zone diameter for 4HQZN is determined to be 18 mm. Generally, the inhibition zone diameters of the nitrate complex 4HQZN are larger for all microbes compared to the 4HQZ. Hence, one could conclude the higher antibacterial and antifungal activities of 4HQZN than 4HQZ against all the investigated microbes. The inhibition zone diameters range from 9 mm (C. albicans and B. subtilis) to 11 mm (E. coli and P. vulgaris) for 4HQZ. The corresponding values for 4HQZN are 10 mm (C. albicans) and 18 mm (A. fumigatus). Generally, both compounds could be considered as a broad-spectrum antimicrobial agent against the selected Gram positive and Gram negative bacterial strains and the fungus C. albicans as well.
The Minimum Inhibitory Concentrations (MIC, in μg/mL) presented in Table 8 indicated higher potency of 4HQZN than 4HQZ against all microbes. For all microbes (except B. subtilis), the 4HQZN has lower MIC values than 4HQZ. The former has higher potency against the fungus A. fumigatus and C. albicans as well as the bacteria S. aureus, E. coli and P. vulgaris than the latter. The most promising result is for 4HQZN against A. fumigatus with MIC value of 312.5 μg/mL compared to 156.25 μg/mL for Ketoconazole. The rest of MIC values are significantly higher than those for the standard drugs ketoconazole and gentamycin as antifungal and antibacterial drugs, respectively.

3. Experimental

3.1. Materials and Physical Measurements

All chemicals including 4-hydroxyquinozaline (4HQZ) were purchased from Sigma-Aldrich Chemical Company Inc. (St. Louis, MO, USA). Elemental analyses (CHN) were measured using a model 2400 instrument (Perkin-Elmer, city, state abbreviation if USA, country). The FTIR spectra were measured at 4000–400 cm−1 using a Tensor 37 FTIR instrument (Bruker, city, state abbreviation if USA, country) in KBr pellets.

3.2. Synthesis of 4HQZN

4HQZN was obtained by mixing 0.292 g (2 mmol) of 4HQZ in ethanol with 1 mL of 0.2 mol/L nitric acid (2 mmol). A white precipitate was immediately obtained which was then dissolved in acetonitrile. After five days, pure colorless needle crystals of the target compound 4HQZN were obtained. Yield; C8H7N3O4 87%; m.p. = 194–196 °C. Anal. Calc. C, 45.94; H, 3.37; N, 20.09%. Found: C, 45.81; H, 3.30; N, 20.17%. IR (KBr, cm−1): 3417, 3099, 3067, 1659, 1609, 1718, 1385 (Figure S1, Supplementary Materials).

3.3. Crystal Structure Determination

The determination of the crystal structure of 4HQZN was performed using the procedures described in the Supplementary Materials [55,56].

3.4. Biological Studies

The antimicrobial activity of 4HQZ and 4HQZN against different microbes and their antioxidant activity were performed according the procedures mentioned in Methods S1 and S2 (Supplementary Materials). Also, evaluation of cytotoxic activities against breast MCF-7 and lung A-549 carcinoma cell lines were performed following the procedure mentioned in Method S3.

3.5. Computational Details

Crystal Explorer 17.5 program [57] was used for Hirshfeld analysis. The structures of the studied isomers shown in Figure 3 were calculated using Gaussian 09 program [58,59,60,61,62]. Further details are found in Supplementary Materials.

4. Conclusions

The molecular and supramolecular structure aspects of 4HQZN were investigated using different experimental and theoretical procedures. The crystal structure of 4HQZN was analyzed using topology analysis with the aid of Hirshfeld calculations. Its supramolecular structure could be described as a 2D infinite layers of hydrogen-bonded 4HQZN molecules. Five possible isomers of 4HQZN were calculated using DFT calculations and their relative stabilities were compared. Also, the effect of solvent on the isomers’ stability was predicted. The results shed the light on the importance of the intra- and inter-molecular interactions on the isomers’ stability. 4HQZN has higher antioxidant and antibacterial activities than 4HQZ. In contrast, 4HQZ has higher anticancer activity against breast carcinoma MCF-7 and lung carcinoma A-549 cell lines than 4HQZN.

Supplementary Materials

Crystal structure determination; Computational DFT details; Method S1: Antimicrobial studies; Method S2: DPPH Radical Scavenging Activity; Method S3: Evaluation of Cytotoxic activity; Figure S1. FTIR spectra of 4HQZN and 4HQZ; Table S1. Crystal data for 4HQZN; Table S2. Optimized bond distances and angles of the 4HQZN (isomer E1) compared to the experimental X-ray structure results a; Table S3. Natural charges at the different atomic sites of 4HQZN (isomer E1) a; Table S4. Evaluation of Antioxidant Activity using DPPH scavenging assay for 4HQZ; Table S5. Evaluation of Antioxidant Activity using DPPH scavenging assay for 4HQZN; Table S6. Evaluation of cytotoxicity against Breast carcinoma MCF-7 cell line for 4HQZ; Table S7. Evaluation of cytotoxicity against Breast carcinoma MCF-7 cell line for 4HQZN; Table S9. Evaluation of cytotoxicity against lung carcinoma A549 cell line for 4HQZN.

Author Contributions

Conceptualization, S.M.S. and M.A.M.A.-Y.; methodology, E.M.F., J.H.A., A.M.A.B. and A.B.; software, S.M.S., M.S.A.; A.M.A.B. and A.B.; formal analysis, E.M.F., A.M.A.B. and M.S.A.; investigation, S.M.S., A.M.A.B. and E.M.F.; resources, M.S.A., M.A.M.A.-Y. and A.B.; writing—original draft preparation, S.M.S., E.M.F., M.A.M.A.-Y., A.M.A.B. and A.B.; writing—review and editing, S.M.S., E.M.F., M.A.M.A.-Y., A.M.A.B. and A.B.; supervision, S.M.S. and M.A.M.A.-Y.; project administration, M.S.A., A.B., S.M.S. and M.A.M.A.-Y.; funding acquisition, M.S.A. All authors have read and agreed to the published version of the manuscript.

Funding

Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2022R86), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2022R86), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are available from the authors.

References

  1. Mishra, B.B.; Kumar, D.; Mishra, A.; Mohapatra, P.P.; Tiwari, V.K. Cyclo-Release Strategy in Solid-Phase Combinatorial Synthesis of Heterocyclic Skeletons. Adv. Heterocycl. Chem. 2012, 107, 41–99. [Google Scholar]
  2. Kaur, N. Chapter 4. Metal- and Non-Metal-Assisted Synthesis of Six-Membered N,N-Heterocycles. In Metal and Nonmetal Assisted Synthesis of Six-Membered Heterocycles; Elsevier: Amsterdam, The Netherlands, 2020; pp. 183–241. [Google Scholar] [CrossRef]
  3. Jen, T.; Dienel, B.; Dowalo, F.; Van Hoeven, H.; Bender, P.; Loev, B. Amidines. 5. Synthesis of pyrrolo [2, 3-b] isoquinoline imidazo [1, 2-b] isoquinoline, pyrrolo [2, 1-b] quinazoline, and 1, 3-thiazino [2, 3-b] quinazoline derivatives and related heterocycles as potential antihypertensive agents. J. Med. Chem. 1973, 16, 633–637. [Google Scholar] [CrossRef] [PubMed]
  4. Hameed, A.; Al-Rashida, M.; Uroos, M.; Ali, S.A.; Ishtiaq, A.M.; Khan, K.M. Quinazoline and quinazolinone as important medicinal scaffolds: A comparative patent review (2011–2016). Expert Opin. Ther. Pat. 2018, 28, 281–297. [Google Scholar] [CrossRef]
  5. Mahato, A.K.; Srivastava, B.; Nithya, S. Chemistry, structure activity relationship and biological activity of quinazoline-4 (3H)-one derivatives. Inventi Rapid Med. Chem. 2011, 2, 13–19. [Google Scholar]
  6. Faisal, M.; Saeed, A. Chemical insights into the synthetic chemistry of quinazolines: Recent advances. Front. Chem. 2021, 8, 1204. [Google Scholar] [CrossRef]
  7. Al-Salahi, R.; Taie, H.A.; Bakheit, A.H.; Marzouk, M.; Almehizia, A.A.; Herqash, R.; Abuelizz, H.A. Antioxidant activities and molecular docking of 2-thioxobenzo [g] quinazoline derivatives. Pharmacol. Rep. 2019, 71, 695–700. [Google Scholar] [CrossRef]
  8. Devipriya, D.; Roopan, S.M. UV-light intervened synthesis of imidazo fused quinazoline and its solvatochromism, antioxidant, antifungal and luminescence properties. J. Photochem. Photobiol. B Biol. 2019, 190, 42–49. [Google Scholar] [CrossRef] [PubMed]
  9. Dixit, A.; Pathak, D.; Sharma, G.K. Synthesis, antibacterial and antioxidant activity of novel 12-(N-arylmethaniminyl) indolo [1, 2-c] quinazolines. J. Res. Pharm. 2019, 23, 584–595. [Google Scholar] [CrossRef] [Green Version]
  10. Saeedi, M.; Mohammadi-Khanaposhtani, M.; Pourrabia, P.; Razzaghi, N.; Ghadimi, R.; Imanparast, S.; Faramarzi, M.A.; Bandarian, F.; Esfahani, E.N.; Safavi, M.; et al. Design and synthesis of novel quinazolinone-1, 2, 3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study. Bioorg. Chem. 2019, 83, 161–169. [Google Scholar] [CrossRef]
  11. Barmak, A.; Niknam, K.; Mohebbi, G. Synthesis, Structural Studies, and α-Glucosidase Inhibitory, Antidiabetic, and Antioxidant Activities of 2, 3-Dihydroquinazolin-4 (1 H)-ones Derived from Pyrazol-4-carbaldehyde and Anilines. ACS Omega 2019, 4, 18087–18099. [Google Scholar] [CrossRef] [Green Version]
  12. Khanaposhtani, M.M.; Yahyavi, H.; Imanparast, S.; Harandi, F.N.; Faramarzi, M.A.; Foroumadi, A.; Larijani, B.; Biglar, M.; Mahdavi, M. Benzoylquinazolinone derivatives as new potential antidiabetic agents: α- Glucosidase inhibition, kinetic, and docking studies. J. Chin. Chem. Soc. 2020, 67, 856–863. [Google Scholar] [CrossRef]
  13. Zhang, L.; Chen, Q.; Li, X.Q.; Wu, S.Q.; Wan, J.L.; Ouyang, G.P. Synthesis and Antibacterial Activity of 2-substitued-(3-pyridyl)-quinazolinone Derivatives. J. Heterocycl. Chem. 2018, 55, 743–749. [Google Scholar] [CrossRef]
  14. Ankireddy, A.R.; Syed, R.; Gundla, R.; Manasa, K.L.; Reddy, C.V.R.; Yatam, S.; Paidikondala, K. Kumada cross coupling reaction for the synthesis of quinazo-line derivatives, evaluation of their antibacterial activity and docking studies. Russ. J. Gen. Chem. 2019, 89, 2544–2557. [Google Scholar] [CrossRef]
  15. Shao, W.B.; Zheng, Y.T.; Liu, J.M.; Fu, Y.H.; Qi, P.Y.; Zhou, X.; Wu, Z.B.; Wang, P.Y.; Yang, S. Antibacterial activities against Ralstonia solanacearum and Xanthomonas oryzae pv. oryzae of 6-chloro-4-(4-substituted piperazinyl) quinazoline derivatives. Bioorg. Med. Chem. 2020, 30, 126912. [Google Scholar] [CrossRef]
  16. Wang, M.; Zhang, G.; Wang, Y.; Wang, J.; Zhu, M.; Cen, S.; Wang, Y. Design, synthesis and anti-influenza A virus activity of novel 2, 4-disubstituted quinazoline derivatives. Bioorg. Med. Chem. 2020, 30, 127143. [Google Scholar] [CrossRef] [PubMed]
  17. Xie, D.; Shi, J.; Zhang, A.; Lei, Z.; Zu, G.; Fu, Y.; Gan, X.; Yin, L.; Song, B.; Hu, D. Syntheses, antiviral activities and induced resistance mechanisms of novel quinazoline derivatives containing a dithioacetal moiety. Bioorg. Chem. 2018, 80, 433–443. [Google Scholar] [CrossRef] [PubMed]
  18. Abbas, S.Y.; El-Bayouki, K.A.; Basyouni, W.M.; Mostafa, E.A. New series of 4(3H)-quinazolinone derivatives: Syntheses and evaluation of antitumor and antiviral activities. Med. Chem. Res. 2018, 27, 571–582. [Google Scholar] [CrossRef]
  19. Du, H.; Ding, M.; Luo, N.; Shi, J.; Huang, J.; Bao, X. Design, synthesis, crystal structure and in vitro antimicrobial activity of novel 1, 2, 4-triazolo [1, 5-a] pyrimidine-containing quinazolinone derivatives. Mol. Divers. 2021, 25, 711–722. [Google Scholar] [CrossRef]
  20. Fan, Z.; Shi, J.; Bao, X. Synthesis and antimicrobial evaluation of novel 1, 2, 4-triazole thioether derivatives bearing a quinazoline moiety. Mol. Divers. 2018, 22, 657–667. [Google Scholar] [CrossRef]
  21. Yang, L.; Ge, S.; Huang, J.; Bao, X. Synthesis of novel (E)-2-(4-(1 H-1, 2, 4-triazol-1-yl) styryl)-4-(alkyl/arylmethyleneoxy) quinazoline derivatives as antimicrobial agents. Mol. Divers. 2018, 22, 71–82. [Google Scholar] [CrossRef]
  22. Perupogu, N.; Krishna, C.; Ramachandran, D. Design, Synthesis and Anticancer Evaluation of 1, 2, 4-thiadiazole linked Benzoxazole-Quinazoline Derivatives. Chem. Data. Collect. 2020, 28, 100482. [Google Scholar] [CrossRef]
  23. Hu, H.; Dong, Y.; Li, M.; Wang, R.; Zhang, X.; Gong, P.; Zhao, Y. Design, synthesis and biological evaluation of novel thieno [3, 2-d] pyrimidine and quinazoline derivatives as potent antitumor agents. Bioorg. Chem. 2019, 90, 103086. [Google Scholar] [CrossRef]
  24. Gobinath, M.; Subramanian, N.; Alagarsamy, V.; Nivedhitha, S.; Solomon, V.R. Design and Synthesis of 1-Substituted-4-(4-Nitrophenyl)-[1, 2, 4] triazolo [4, 3-a] quinazolin-5 (4 H)-ones as a New Class of Antihistaminic Agents. Russ. J. Bioorg. Chem. 2020, 46, 403–408. [Google Scholar] [CrossRef]
  25. Alagarsamy, V.; Parthiban, P.; Solomon, V.R.; Dhanabal, K.; Murugesan, S.; Saravanan, G.; Anjana, G.V. Synthesis and pharmacological investigation of novel 4-(4-Ethyl phenyl)-1-substituted-4H-[1, 2, 4] triazolo [4, 3-a]-quinazolin-5-ones as new class of H1-antihistaminic agents. J. Heterocycl. Chem. 2008, 45, 709–715. [Google Scholar] [CrossRef] [Green Version]
  26. Alagarsamy, V.; Parthiban, P. Design and synthesis of novel 2-(3-substituted propyl)-3-(2-methyl phenyl) quinazolin-4-(3 H)-ones as a new class of H1-antihistaminic agents. J. Enzyme Inhib. Med. Chem. 2013, 28, 65–71. [Google Scholar] [CrossRef] [PubMed]
  27. Rahman, M.U.; Rathore, A.; Siddiqui, A.A.; Parveen, G.; Yar, M.S. Synthesis and characterization of quinazoline derivatives: Search for hybrid molecule as diuretic and antihypertensive agents. J. Enzyme Inhib. Med. Chem. 2014, 29, 733–743. [Google Scholar] [CrossRef]
  28. Rosenberg, J.; Gustafsson, F.; Galatius, S.; Hildebrandt, P.R. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: An observational study and review of the literature. Cardiovasc. Drugs Ther. 2005, 19, 301–306. [Google Scholar] [CrossRef]
  29. Malasala, S.; Ahmad, M.N.; Gour, J.; Shukla, M.; Kaul, G.; Akhir, A.; Gatadi, S.; Madhavi, Y.V.; Chopra, S.; Nanduri, S. Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents. J. Mol. Struct. 2020, 1218, 128493. [Google Scholar] [CrossRef]
  30. Gawad, J.; Bonde, C. Design, synthesis and biological evaluation of novel 6-(trifluoromethyl)-N-(4-oxothiazolidin-3-yl) quinazoline-2-carboxamide derivatives as a potential DprE1 inhibitors. J. Mol. Struct. 2020, 1217, 128394. [Google Scholar] [CrossRef]
  31. Rajasekhar, K.K.; Nizamuddin, N.D.; Surur, A.S.; Mekonnen, Y.T. Synthesis, characterization, antitubercular and antibacterial activity, and molecular docking of 2, 3-disubstituted quinazolinone derivatives. Res. Rep. Med. Chem. 2016, 6, 15–26. [Google Scholar]
  32. Martynenko, Y.; Antypenko, O.; Nosulenko, I.; Berest, G.; Kovalenko, S. Directed Search of Anti-inflammatory Agents Among (3H-Quinazoline-4-ylidene) hydrazides of N-protected Amino acids and their Heterocyclization Products. Anti Inflamm. Anti Allergy Agents Med. Chem. 2020, 19, 61–73. [Google Scholar]
  33. Alagarsamy, V.; Solomon, V.R.; Murugan, M.; Sankaranarayanan, R.; Periyasamy, P.; Deepa, R.; Anandkumar, T.D. Synthesis of 3-(2-pyridyl)-2-substituted-quinazolin-4 (3H)-ones as new analgesic and anti-inflammatory agents. Biomed. Pharmacother. 2008, 62, 454–461. [Google Scholar] [CrossRef]
  34. El-Sayed, E.H.; Mohamed, K.S. Synthesis and Anti-inflammatory Evaluation of Some New Pyrazole, Pyrimidine, Pyrazolo [1, 5-a] Pyrimidine, Imidazo [1, 2-b] Pyrazole and Pyrazolo [5, 1-b] Quinazoline Derivatives Containing Indane Moiety. Polycycl. Aromat. Compd. 2019, 41, 1077–1093. [Google Scholar] [CrossRef]
  35. Auti, P.S.; George, G.; Paul, A.T. Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids. RSC Adv. 2020, 10, 41353–41392. [Google Scholar] [CrossRef]
  36. Connolly, D.J.; Cusack, D.; O’Sullivan, T.; Guiry, P.J. Synthesis of quinazolinones and quinazolines. Tetrahedron 2005, 61, 10153–10202. [Google Scholar] [CrossRef]
  37. Nayyar, P.; Arpana, R.; Mohd, I. An updated review: Newer quinazoline derivatives under clinical trial. Int. J. Pharm. Biol. Sci. Arch. 2011, 2, 1651–1657. [Google Scholar]
  38. Mhaske, S.B.; Argade, N.P. The chemistry of recently isolated naturally occurring quinazolinone alkaloids. Tetrahedron 2006, 62, 9787–9826. [Google Scholar] [CrossRef]
  39. Witt, A.; Bergman, J. Recent developments in the field of quinazoline chemistry. Curr. Org. Chem. 2003, 7, 659–677. [Google Scholar] [CrossRef]
  40. Cho, S.J.; Mohamed, A.A.; Elroby, S.A. Theoretical investigation of the tautomerism of isoorotic acid in gaseous and aqueous phases. J. Quantum Chem. 2007, 107, 63–71. [Google Scholar] [CrossRef]
  41. Karelson, M.M.; Katritzky, A.R.; Szafran, M.; Zerner, M.C. Quantitative predictions of tautomeric equilibria for 2-, 3-, and 4-substituted pyridines in both the gas phase and aqueous solution: Combination of AM1 with reaction field theory. J. Org. Chem. 1989, 54, 6030–6034. [Google Scholar] [CrossRef]
  42. Wong, M.W.; Leung-Toung, R.; Wentrup, C. Tautomeric equilibrium and hydrogen shifts of tetrazole in the gas phase and in solution. J. Am. Chem. Soc. 1993, 115, 2465–2472. [Google Scholar] [CrossRef]
  43. Parchment, O.G.; Green, D.V.; Taylor, P.J.; Hillier, I.H. The prediction of tautomer equilibria in hydrated 3-hydroxypyrazole: A challenge to theory. J. Am. Chem. Soc. 1993, 115, 2352–2356. [Google Scholar] [CrossRef]
  44. Cieplak, P.; Bash, P.; Singh, U.C.; Kollman, P.A. A theoretical study of tautomerism in the gas phase and aqueous solution: A combined use of state-of-the-art ab initio quantum mechanics and free energy-perturbation methods. J. Am. Chem. Soc. 1987, 109, 6283–6289. [Google Scholar] [CrossRef]
  45. Cao, M.; Teppen, B.J.; Miller, D.M.; Pranata, J.; Schafer, L. Tautomeric equilibria of 3-hydroxypyrazole in the gas phase and in solution: A theoretical study combining ab initio quantum mechanics and Monte Carlo simulation methods. J. Phys. Chem. 1994, 98, 11353–11361. [Google Scholar] [CrossRef]
  46. Cramer, C.J.; Truhlar, D.G. Correlation and solvation effects on heterocyclic equilibria in aqueous solution. J. Am. Chem. Soc. 1993, 115, 8810–8817. [Google Scholar] [CrossRef]
  47. Orozco, M.; Luque, F.J. Self-consistent reaction field computation of the reactive characteristics of DNA bases in water. Biopolymers 1993, 33, 1851–1869. [Google Scholar] [CrossRef]
  48. Kwiatkowski, J.S.; Bartlett, R.J.; Person, W.B. Contributions from electron correlation to the relative stabilities of the tautomers of nucleic acid bases. J. Am. Chem. Soc. 1988, 110, 2353–2358. [Google Scholar] [CrossRef]
  49. Polat, T.; Yurdakul, Ş. Structure and vibrational assignment of tautomerism of 4-hydroxyquinazoline in gaseous and aqueous phases. J. Mol. Struct. 2011, 1001, 16–22. [Google Scholar] [CrossRef]
  50. Nataraj, A.; Balachandran, V.; Karthick, T. Molecular structure, vibrational spectra, first hyperpolarizability and HOMO–LUMO analysis of p-acetylbenzonitrile using quantum chemical calculation. J. Mol. Struct. 2013, 1038, 134–144. [Google Scholar] [CrossRef]
  51. Ruiz-Morales, Y. HOMO−LUMO gap as an index of molecular size and structure for polycyclic aromatic hydrocarbons (PAHs) and asphaltenes: A theoretical study. I. J. Phys. Chem. A. 2002, 106, 11283–11308. [Google Scholar] [CrossRef]
  52. Blois, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  53. Yen, G.C.; Duh, P.D. Scavenging effect of methanolic extracts of peanut hulls on free radical and active oxygen species. J. Agric. Food Chem. 1994, 42, 629–632. [Google Scholar] [CrossRef]
  54. Clifford, T.; Howatson, G.; West, D.J.; Stevenson, E.J. The potential benefits of red beetroot supplementation in health and disease. Nutrients 2015, 7, 2801–2822. [Google Scholar] [CrossRef]
  55. Sheldrick, G.M. SADABS, Program for Empirical Absorption Correction of Area Detector Data; University of Gttingen: Gttingen, Germany, 1996. [Google Scholar]
  56. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  57. Turner, M.J.; McKinnon, J.J.; Wolff, S.K.; Grimwood, D.J.; Spackman, P.R.; Jayatilaka, D.; Spackman, M.A. Crystal Explorer 17; University of Western Australia: Crawley, Australia, 2017. [Google Scholar]
  58. Foresman, J.B.; Frisch, A.E. Exploring Chemistry with Electronic Structure Methods, 2nd ed.; Gaussian: Pittsburgh, PA, USA, 1996. [Google Scholar]
  59. Dennington, R., II; Keith, T.; Millam, J. GaussView, version 4.1, Semichem Inc.: Shawnee Mission, KS, USA, 2007.
  60. Becke, A.D. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. A 1988, 38, 3098–3100. [Google Scholar] [CrossRef] [PubMed]
  61. Wang, W.; Mortier, W.J. The use of global and local molecular parameters for the analysis of the gas-phase basicity of amines. J. Am. Chem. Soc. 1986, 108, 5708–5711. [Google Scholar]
  62. Glendening, E.D.; Reed, A.E.; Carpenter, J.E.; Weinhold, F. NBO, Version 3.1, University of Wisconsin: Madison, WI, USA, 1998.
Molecules 27 01089 g001 550
Figure 1. Structure of some quinazoline/quinazolidinone-based medicines.
Figure 1. Structure of some quinazoline/quinazolidinone-based medicines.
Molecules 27 01089 g001
Molecules 27 01089 g002 550
Figure 2. Isomeric forms of 4-hydroxyquinazoline (4-HQZ).
Figure 2. Isomeric forms of 4-hydroxyquinazoline (4-HQZ).
Molecules 27 01089 g002
Molecules 27 01089 g003 550
Figure 3. Isomeric forms of 4HQZN.
Figure 3. Isomeric forms of 4HQZN.
Molecules 27 01089 g003
Molecules 27 01089 g004 550
Figure 4. Structure of 4HQZN.
Figure 4. Structure of 4HQZN.
Molecules 27 01089 g004
Molecules 27 01089 g005 550
Figure 5. Packing scheme of 4HQZN. Part (A) shows a projection along 100, part (B) along the monoclinic b-axis 010.
Figure 5. Packing scheme of 4HQZN. Part (A) shows a projection along 100, part (B) along the monoclinic b-axis 010.
Molecules 27 01089 g005
Molecules 27 01089 g006 550
Figure 6. View of layered packing along b-axis. The number indicated the alternating layer distances in (Å).
Figure 6. View of layered packing along b-axis. The number indicated the alternating layer distances in (Å).
Molecules 27 01089 g006
Molecules 27 01089 g007 550
Figure 7. Hydrogen bridges in the 2-dimensional infinite layers occurring in the crystal structure of 4HQZN. All hydrogen bridges are presented as light blue, broken lines. Hydrogen bond parameters are listed in Table 2.
Figure 7. Hydrogen bridges in the 2-dimensional infinite layers occurring in the crystal structure of 4HQZN. All hydrogen bridges are presented as light blue, broken lines. Hydrogen bond parameters are listed in Table 2.
Molecules 27 01089 g007
Molecules 27 01089 g008 550
Figure 8. Hirshfeld surfaces mapped over shape index (SI), curvedness as well as dnorm for the studied five fragments (F1 to F5) of 4HQZN.
Figure 8. Hirshfeld surfaces mapped over shape index (SI), curvedness as well as dnorm for the studied five fragments (F1 to F5) of 4HQZN.
Molecules 27 01089 g008
Molecules 27 01089 g009 550
Figure 9. Intermolecular interactions in the protonated 4HQZ (F1) and nitrate (F2) fragments. Hirshfeld analysis of the four nitrate fragments gave the same results, hence only one is presented.
Figure 9. Intermolecular interactions in the protonated 4HQZ (F1) and nitrate (F2) fragments. Hirshfeld analysis of the four nitrate fragments gave the same results, hence only one is presented.
Molecules 27 01089 g009
Molecules 27 01089 g010 550
Figure 10. Hirshfeld analysis of the nitrate fragment (F2).
Figure 10. Hirshfeld analysis of the nitrate fragment (F2).
Molecules 27 01089 g010
Molecules 27 01089 g011 550
Figure 11. Hirshfeld analysis of the protonated 4HQZ fragment (F1).
Figure 11. Hirshfeld analysis of the protonated 4HQZ fragment (F1).
Molecules 27 01089 g011
Molecules 27 01089 g012 550
Figure 12. Optimized structures of the most stable isomers of 4HQZN in different solvents. The intramolecular hydrogen bond contact distances are depicted in Table 5.
Figure 12. Optimized structures of the most stable isomers of 4HQZN in different solvents. The intramolecular hydrogen bond contact distances are depicted in Table 5.
Molecules 27 01089 g012
Molecules 27 01089 g013 550
Figure 13. FMOs (HOMO; (a) and LUMO; (b)) in gas phase, cyclohexane, DMSO and methanol, from up to down, respectively.
Figure 13. FMOs (HOMO; (a) and LUMO; (b)) in gas phase, cyclohexane, DMSO and methanol, from up to down, respectively.
Molecules 27 01089 g013
Molecules 27 01089 g014 550
Figure 14. The antioxidant activity of 4HQZ and 4HQZN.
Figure 14. The antioxidant activity of 4HQZ and 4HQZN.
Molecules 27 01089 g014
Molecules 27 01089 g015 550
Figure 15. The cytotoxic activity of 4HQZ and 4HQZN against breast (a) and lung carcinoma (b).
Figure 15. The cytotoxic activity of 4HQZ and 4HQZN against breast (a) and lung carcinoma (b).
Molecules 27 01089 g015
Table
Table 1. Bond lengths (Å) and angles (°).
Table 1. Bond lengths (Å) and angles (°).
Bond Lengths
C(1)-N(2)1.3068(12)C(4)-N(2)1.3998(12)
C(1)-N(3)1.3281(12)C(5)-C(6)1.3828(15)
C(2)-O(4)1.2141(12)C(6)-C(7)1.3984(15)
C(2)-N(3)1.4057(12)C(7)-C(8)1.3838(14)
C(2)-C(3)1.4652(13)
C(3)-C(8)1.4004(13) N(1)-O(1)1.2470(10)
C(3)-C(4)1.4009(13)N(1)-O(2)1.2530(11)
C(4)-C(5)1.3955(13)N(1)-O(3)1.2622(10)
Bond Angles
C(1)-N(2)-C(4)121.44(8) C(5)-C(4)-C(3)121.30(9)
C(1)-N(3)-C(2)123.88(8)N(2)-C(4)-C(3)118.67(8)
N(2)-C(1)-N(3)121.89(9)C(6)-C(5)-C(4)118.65(9)
O(4)-C(2)-N(3)120.17(9) C(5)-C(6)-C(7)120.66(9)
O(4)-C(2)-C(3)125.69(9)C(8)-C(7)-C(6)120.70(9)
N(3)-C(2)-C(3)114.14(8)C(7)-C(8)-C(3)119.44(9)
C(8)-C(3)-C(4)119.24(9)
C(8)-C(3)-C(2)120.87(9)O(1)-N(1)-O(2)120.28(8)
C(4)-C(3)-C(2)119.88(8)O(1)-N(1)-O(3)119.39(8)
C(5)-C(4)-N(2)120.03(9)O(2)-N(1)-O(3)120.31(8)
Table
Table 2. Hydrogen bonds in 4HQZN (Å, °). a
Table 2. Hydrogen bonds in 4HQZN (Å, °). a
D-H…Ad(D-H)d(H…A)d(D…A)<(DHA)
N(3)-H(3)…O(2)#10.875(15)1.911(16)2.7790(11)171.2(14)
N(2)-H(2)…O(3)#20.914(14)1.881(15)2.7943(11)176.3(13)
N(2)-H(2)…O(1)#20.914(14)2.391(14)2.9950(12)123.6(11)
C(5)-H(5)…O(1)#30.952.363.1953(13)147
C(6)-H(6)…O(2)#10.952.733.5690(13)148.1
C(8)-H(8)…O(4)#10.952.53.4461(13)176.6
C(1)-H(1)…O(3)#10.952.353.0961(12)135.5
C(1)-H(1)…O(1)#20.952.372.9920(13)123
Symmetry transformations: #1 – x + 1,y – 1/2, –z + 1/2, #2 x + 1,y,z, #3 –x + 1,y + 1/2, –z + 1/2. a DFIX command was used.
Table
Table 3. The short O…H, C…O, C…N and C…C intermolecular contacts.
Table 3. The short O…H, C…O, C…N and C…C intermolecular contacts.
ContactDistance (Å)ContactDistance (Å)
C2…C23.155H1…O12.297
C4…N13.134H1…O32.253
C1…O43.158H2…O12.339
C2…O43.093H2…O31.787
C3…O43.156H3…O21.799
C1…O43.158H5…O12.247
H8…O42.364
Table
Table 4. Energetics and thermodynamic parameters a of the five isomers of 4HQZN.
Table 4. Energetics and thermodynamic parameters a of the five isomers of 4HQZN.
ParameterE1E2E3E4E5
Gas
E−774.161−774.158−774.151−774.177−774.15
ZPVE b0.15640.15660.15570.15690.1558
Ecorr c−774.004−774.002−773.995−774.02−773.994
∆E9.608611.319715.3745016.1
H−773.991−773.988−773.981−774.006−773.98
S116.539118.847117.635114.764118.397
G−774.046−774.044−774.037−774.061−774.036
Methanol
E−774.195−774.185−774.178−774.189−774.168
ZPVE b0.1570.15480.15670.15580.1541
Ecorr c−774.038−774.031−774.022−774.033−774.014
∆E04.456510.13342.748214.7667
H−774.024−774.017−774.008−774.02−774.001
S118.292116.599117.834115.358116.384
G−774.08−774.073−774.064−774.075−774.056
DMSO
E−774.195−774.186−774.179−774.189−774.169
ZPVE b0.1570.15460.15670.15580.1539
Ecorr c−774.038−774.031−774.022−774.034−774.015
∆E04.470310.22893.033614.8717
H−774.025−774.018−774.008−774.02−774.001
S118.389116.655117.771115.372116.514
G−774.081−774.073−774.064−774.075−774.056
Cyclohexane
E−774.17−774.169−774.158−774.181−774.157
ZPVE b0.15590.15640.15530.15650.1557
Ecorr c−774.014−774.012−774.003−774.025−774.001
∆E6.53397.815313.7591014.7695
H−774.001−773.999−773.989−774.012−773.988
S116.365117.962116.737114.879117.226
G−774.056−774.055−774.045−774.066−774.043
a in a.u. except ∆E in kcal·mol−1 and S in cal·mol−1K−1; b zero point energy correction; c E + ZPVE.
Table
Table 5. Effect of solvent on the intramolecular hydrogen bond distances in the most stable isomers E1 and E4.
Table 5. Effect of solvent on the intramolecular hydrogen bond distances in the most stable isomers E1 and E4.
MediumA aB aC aD a
Gas1.64-1.5431.932
Cyclohexane1.563-1.5131.971
DMSO-1.6641.4622.023
Methanol-1.6611.4632.021
a The definition of the intramolecular hydrogen bonds A, B, C and D is shown in Figure 12.
Table
Table 6. The FMOs energies (e.v) in gas phase and different solvents.
Table 6. The FMOs energies (e.v) in gas phase and different solvents.
MediumEHOMOELUMO∆E
Gas−7.389−2.3425.047
Cyclohexane−7.2673−2.2365.031
DMSO−7.128−2.4994.630
Methanol−7.114−2.5064.608
Table
Table 7. Inhibition zone diameters of 4HQZ and 4HQZN.
Table 7. Inhibition zone diameters of 4HQZ and 4HQZN.
Microbe4HQZ4HQZNControl
A. fumigatusNA1819 a
C. albicans91020 a
S. aureus101124 b
B. subtilis91126 b
E. coli111430 b
P. vulgaris111325 b
a Ketoconazole and b gentamycin.
Table
Table 8. MIC values (μg/mL) for 4HQZN than 4HQZ.
Table 8. MIC values (μg/mL) for 4HQZN than 4HQZ.
Microbe4HQZ4HQZNControl
A. fumigatusNA312.5156.25 a
C. albicans50002500312.5 a
S. aureus250012509.7 b
B. subtilis250025004.9 b
E. coli12506254.9 b
P. vulgaris12506254.9 b
a Ketoconazole and b gentamycin.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Fathalla, E.M.; Altowyan, M.S.; Albering, J.H.; Barakat, A.; Abu-Youssef, M.A.M.; Soliman, S.M.; Badr, A.M.A. Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex. Molecules 2022, 27, 1089. https://doi.org/10.3390/molecules27031089

AMA Style

Fathalla EM, Altowyan MS, Albering JH, Barakat A, Abu-Youssef MAM, Soliman SM, Badr AMA. Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex. Molecules. 2022; 27(3):1089. https://doi.org/10.3390/molecules27031089

Chicago/Turabian Style

Fathalla, Eman M., Mezna Saleh Altowyan, Jörg H. Albering, Assem Barakat, Morsy A. M. Abu-Youssef, Saied M. Soliman, and Ahmed M. A. Badr. 2022. "Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex" Molecules 27, no. 3: 1089. https://doi.org/10.3390/molecules27031089

APA Style

Fathalla, E. M., Altowyan, M. S., Albering, J. H., Barakat, A., Abu-Youssef, M. A. M., Soliman, S. M., & Badr, A. M. A. (2022). Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex. Molecules, 27(3), 1089. https://doi.org/10.3390/molecules27031089

Article Metrics

Back to TopTop